Invigor secures WeChat Pay deployment in Singapore with Club 21

|

Published 10-APR-2019 10:26 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Data and analytics solutions company, Invigor Group Limited (ASX:IVO), has secured a multi-brand deployment of the WeChat Pay platform in Singapore.

The company has signed an agreement with Club 21, which is one of Asia’s leading luxury goods retailers.

A subsidiary of COMO Group, Club 21 has some 3,800 employees and 250 brands across nearly 400 stores in Australia, China, Hong Kong, Indonesia, Malaysia, Singapore, Taiwan, Thailand, the United Kingdom and the United States.

The agreement is a major win for IVO, as it illustrates that leading brands with large brick and mortar networks are integrating with online payment and loyalty platforms (or online-to-offline commerce ‘O2O’) to drive an uptick in sales. IVO and Winning Group are now beginning to drive scale into their Loyalty and Payments operations across Asia.

IVO will work to integrate its proprietary Advertising and Loyalty technology offerings into the WeChat Pay platform targeting predominantly Chinese tourists, which will redeem offers when shopping at Club 21 stores in Singapore.

IVO will earn a share of transaction revenue from these payments, with the WeChat Pay Advertising and Loyalty offering to be rolled out to all 40 Club 21 stores in Singapore. These include the Four Seasons Hotel, the Hilton Hotel and others, plus brands represented by Club 21 including Armani Exchange and Calvin Klein.

IVO CEO Gary Cohen said, “This is without a doubt a major coup for Invigor Group and demonstrates the value of getting their O2O commerce strategy right, and that’s what our integrated WeChat Pay offering helps them achieve.

“It’s without doubt one of Invigor’s most promising developments to date. The roll-out to stores is now occurring and Invigor is also working on further developments with Club 21 including signing on more locations.

“Other major retailers outside of Club 21 are also being pursued and close to signing. The company will also explore future opportunities with Club 21 on new initiatives including Shopper Insights and customer relationship management (CRM) opportunities.”

About Invigor Group

Invigor Group is a B2B data solutions company that converts data into revenue for the retail and service industries.

IVO’s innovation in owned retail platforms and unique cross-channel data systems allows business to have a strong holistic view of their customers and competitive landscape to not only understand, but effectively engage with today’s consumers.

Combined with proprietary data and predictive engines, IVO provides strategic insights and recommendations that empower businesses to successfully influence future strategy and increase profitability.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X